Effects of cysteine upon tumor cells

Area of Science:

• Biochemistry
• Oncology
• Pharmacology

Background:

• Cysteine was previously shown to increase survival in thymoma-bearing mice.
• This effect was attributed to cysteine's chelating action inhibiting tumor cell collagenase.
• An alternative hypothesis suggested cysteine's inhibition of amino acid transport.

Purpose of the Study:

• To investigate the mechanism by which cysteine enhances survival in thymoma-bearing mice.
• To differentiate between collagenase inhibition and amino acid transport inhibition as the cause of enhanced survival.
• To explore the effects of cysteine and its analogs on amino acid transport in tumor cells.

Main Methods:

• Survival studies using S37 ascites tumor cells in mice.
• Assays to measure amino acid transport inhibition by cysteine and its analogs.
• Comparison of effects of cysteine and EDTA (a chelating agent).

Main Results:

• Cysteine was found to be a potent inhibitor of amino acid transport into S37 ascites tumor cells.
• Survival studies with S37 cells did not support amino acid transport inhibition as the primary mechanism for survival enhancement.
• Cysteine and EDTA showed no survival benefit in S37 sarcoma-bearing mice, reinforcing the collagenase inhibition hypothesis for thymomas.
• Other sulfhydryl analogs also inhibited amino acid transport, particularly affecting system L over system A.

Conclusions:

• The survival enhancement observed in thymoma-bearing mice treated with cysteine is likely due to the inhibition of collagenase activity.
• Cysteine's potent inhibition of amino acid transport in tumor cells is a separate effect and not the primary driver of survival benefit in this model.
• The mechanism of cysteine's amino acid transport inhibition may involve metal ion chelation or the gamma-glutamyl cycle.